Facilitator Reference · PGY 1–3
Simulation Day
Procedure Guides
Five procedure stations with weighted scoring, equipment checklists, technique rubrics, and complication probe questions. Critical items (4 pts each) are flagged in red — missed items prompt debrief but do not auto-fail.
Standard step (1–3 pts)
Critical item (4 pts) — debrief if missed
Complication probe question
01
Central Line Placement
IJ and femoral approaches, ultrasound-guided Seldinger technique
IJ: 39 pts · Femoral: 36 pts
02
Cricothyrotomy
Scalpel-finger-bougie technique for CICO scenario
35 pts total
03
Lumbar Puncture
CSF sampling with opening pressure; positioning and aseptic technique
31 pts total
04
Pediatric Intubation
RSI weight-based dosing and technique for toddler (~12 kg)
40 pts total
05
ACLS Management
Full ACLS spectrum — rhythm interpretation, arrest, tachyarrhythmias, bradyarrhythmias, devices
20 pts per rhythm encounter
06
Paracentesis
Diagnostic and large-volume therapeutic paracentesis with ultrasound guidance, Z-track technique, and albumin replacement
35 pts total
07
Thoracentesis
Pleural fluid sampling and drainage with ultrasound guidance; Light's criteria, volume limits, and re-expansion edema prevention
36 pts total
Procedure 01
Central Line Placement
IJ and femoral venous access via ultrasound-guided Seldinger technique. Equipment checklist is shared. Select approach below.
Score
0/39
Performance
Equipment Checklist — Both Approaches
Cap, mask, sterile gown
Sterile gloves
Large sterile drape
Chlorhexidine prep sticks
Ultrasound + sterile probe cover
10 mL syringe (×2)
1% Lidocaine
18g finder needle
J-tip guidewire
Tissue dilator
Triple-lumen catheter (8.5 Fr)
Scalpel (#11 blade)
NS flushes (×3)
3-0 silk suture + needle driver
Tegaderm dressing
Cardiac/SpO2 monitor
Internal Jugular (IJ)
Femoral
IJ Technique — Scored Checklist
39 pts
  • Maximum sterile barrier precautions established
    Cap, mask, gown, gloves, full-body drape — verbalized or performed
    Critical4 pts
  • Patient positioning — Trendelenburg, head turned contralateral
    Head-down 15°; Trendelenburg verbalized to reduce air embolism risk
    2 pts
  • Chlorhexidine prep — allows to dry
    Back-and-forth scrub ≥30 sec; verbalizes waiting for dry before needling
    2 pts
  • Ultrasound identifies IJ vs. carotid artery
    Confirms compressibility (vein), pulsatility (artery); scans for thrombosis; IJ confirmed lateral to carotid
    3 pts
  • Local anesthesia administered
    1% lidocaine; skin wheal then deeper infiltration along needle tract
    2 pts
  • Needle insertion with real-time ultrasound guidance
    45° angle; in-plane or out-of-plane; needle tip visualized at all times
    3 pts
  • Venous blood confirmed before wire advancement
    Dark, non-pulsatile blood freely aspirated; US confirms needle in vein; transduces or sends ABG if uncertain
    Critical4 pts
  • Guidewire advanced without resistance; monitors for ectopy
    Wire passes smoothly; watches monitor for PVCs (wire in RV); withdraws if ectopy occurs
    Critical4 pts
  • Wire control maintained at all times
    Non-dominant hand always holds external wire; never releases; scalpel nick at entry site
    Critical4 pts
  • Dilator advanced and removed over wire
    Firm rotating pressure; subcutaneous tissue only; wire control maintained throughout
    2 pts
  • Catheter placed at correct depth
    Right IJ ≈15 cm; left IJ ≈17 cm; wire visible at distal end before removal
    3 pts
  • Wire fully removed; all lumens capped
    Wire counted and verified; all ports capped immediately; no uncapped lumen left open
    Critical4 pts
  • All lumens aspirated and flushed with saline
    Blood return from each port; all three lumens flushed; no air in line
    2 pts
  • Line secured; occlusive dressing applied
    3-0 silk suture; Tegaderm; date/time/operator labeled
    2 pts
  • CXR ordered for line confirmation
    Verbalized or ordered; checking catheter tip position, pneumothorax, hemothorax
    Critical4 pts
Complication Probe Questions — IJ
QYou aspirate bright red, pulsatile blood. What do you do?
Arterial puncture. Remove needle; apply firm manual pressure for 10–15 minutes. Do NOT dilate or place a catheter. If a large-bore dilator was already placed in the carotid, do not remove — emergent vascular surgery consult.
QPost-procedure CXR shows a large apical lucency on the ipsilateral side. What is it and how do you manage it?
Pneumothorax. Assess for tension (hypotension, tracheal deviation, JVD, absent breath sounds). Tension → needle decompression 2nd ICS MCL then chest tube. Simple, small/asymptomatic → observe. Symptomatic or >20% → chest tube (5th ICS anterior axillary line).
QFrequent PVCs appear during guidewire insertion. What happened?
Wire tip in the right ventricle. Pull back the wire 2–3 cm until ectopy resolves before advancing catheter. Wire should not be advanced past 15–20 cm from IJ entry.
QPatient suddenly desaturates and becomes hypotensive during flushing. What do you suspect?
Air embolism. Immediately left lateral decubitus (Durant maneuver) + Trendelenburg. 100% oxygen. Aspirate air through central line if possible. Prevention: Trendelenburg positioning and always occlude hub during exchanges.
QHow do you reduce CLABSI risk with this line?
Maximum sterile barriers, chlorhexidine prep allowed to dry, antiseptic catheter, avoid femoral when possible, daily line necessity review, scrub hub every access, change dressing every 7 days or when soiled.
Facilitator Notes — IJ
Observations / Debrief Points
Femoral Technique — Scored Checklist
36 pts
  • Maximum sterile barrier precautions established
    Cap, mask, gown, gloves, large drape covering groin except access site
    Critical4 pts
  • Patient positioning — supine, leg slightly abducted/externally rotated
    Small roll under ipsilateral buttock optional; hip slightly extended
    2 pts
  • Chlorhexidine wide-area prep — allows to dry
    Wide prep of groin and thigh; ≥30 sec scrub; must dry before needling
    2 pts
  • Ultrasound identifies femoral vein medial to artery (NAVL anatomy)
    Confirms NAVL (Nerve-Artery-Vein-Lymphatics, lateral to medial); compresses vein; rules out thrombosis; confirms entry BELOW inguinal ligament
    Critical4 pts
  • Local anesthesia administered
    1% lidocaine; skin wheal; deeper infiltration along needle path
    2 pts
  • Needle inserted medial to artery at 45° with ultrasound guidance
    2–3 cm below inguinal ligament; medial to palpable/US-confirmed pulse; continuous aspiration
    3 pts
  • Venous blood confirmed before wire advancement
    Dark, non-pulsatile blood; US confirms needle in compressible vein; does not proceed if bright red/pulsatile
    Critical4 pts
  • Guidewire advanced without resistance; wire control maintained
    Passes smoothly; never forces; controls external wire at all times
    Critical4 pts
  • Scalpel nick; dilator advanced over wire and removed
    Small incision at entry site; rotating pressure; subcutaneous tissue only
    2 pts
  • Catheter placed at appropriate depth (15–20 cm)
    Wire visible at distal end before removal
    3 pts
  • Wire fully removed; all lumens capped immediately
    Wire integrity verified; all ports capped; no uncapped lumen
    Critical4 pts
  • All lumens aspirated and flushed
    Blood return from each port; all lumens flushed; no air in system
    2 pts
  • Line secured with suture and occlusive dressing
    3-0 silk; Tegaderm; date/time/operator labeled
    2 pts
Complication Probe Questions — Femoral
QAfter femoral line placement, patient develops ipsilateral groin/flank pain with falling hematocrit. What do you suspect?
Retroperitoneal hematoma — needle entered above inguinal ligament (external iliac territory). CT A/P with contrast; vascular surgery consult. Prevention: always insert below inguinal ligament; confirm position with US.
QResistance is met when advancing the guidewire. What do you do?
Never force a guidewire. Withdraw slightly, rotate needle, reaspirate to confirm position, reattempt. Resistance means the wire tip is not in the lumen — forcing causes vascular perforation or wire shearing.
QWhat are the major disadvantages of femoral central lines?
Higher CLABSI and DVT risk due to groin colonization and vessel compression. Cannot accurately monitor CVP. Contraindications: known femoral DVT, recent femoral surgery, IVC filter (relative), abdominal trauma with IVC injury. Reserve for cardiac arrest or when upper body access is unavailable.
Facilitator Notes — Femoral
Observations / Debrief Points
Procedure 02
Cricothyrotomy
Surgical airway for cannot-intubate, cannot-oxygenate (CICO). Scalpel-finger-bougie technique. Precede with failed intubation attempt and SpO2 ≤85%.
Scenario cue: Trigger after ≥1 failed intubation attempt with SpO2 ≤85% on BVM. Resident must verbalize "surgical airway" before proceeding.
Score
0/35
Performance
Equipment
Scalpel (#10 or #20 blade)
Tracheal hook
Bougie (gum elastic)
Cuffed ETT 6.0 (or #4 trach tube)
10 mL syringe
BVM with ETCO2 detector
Tape / trach ties
Yankauer suction
SpO2/ETCO2 monitor
PPE (face shield + gloves)
Technique — Scored Checklist (Scalpel-Finger-Bougie)
35 pts
  • Verbalizes CICO scenario and calls for surgical airway
    States "cannot intubate, cannot oxygenate"; calls for cric kit; does not delay
    2 pts
  • Neck extended; anterior neck exposed
    Maximal extension; shoulder roll if available
    2 pts
  • Correctly identifies cricothyroid membrane
    Palpates thyroid notch → thyroid cartilage → soft CTM → firm cricoid; verbalizes landmarks; identifies midline soft spot
    Critical4 pts
  • Stabilizes larynx with non-dominant hand (LMO)
    Thumb and middle finger on thyroid cartilage; index finger palpates CTM
    2 pts
  • Vertical skin incision (3–4 cm) through skin only
    Blade directed caudally; incision through skin and subcutaneous tissue only — not CTM yet
    3 pts
  • Re-identifies CTM by finger palpation
    Index finger confirms CTM after skin incision; clears tissue to expose membrane
    2 pts
  • Horizontal stab incision through CTM
    Single confident horizontal stab in lower third of CTM (avoids superior cricothyroid arteries); directed caudally at 45°; no multiple small cuts
    Critical4 pts
  • Tracheal hook placed; caudal traction applied
    Hook on inferior thyroid cartilage or cricoid; traction caudally to open airway
    2 pts
  • Bougie inserted caudally into trachea
    Directed inferiorly toward carina; tracheal clicks felt as bougie advances
    2 pts
  • ETT 6.0 railroaded over bougie; cuff inflated
    Tube advanced caudally; bougie removed; cuff inflated 10 mL; 15/22 adapter connected to BVM
    Critical4 pts
  • Bilateral breath sounds confirmed by auscultation
    Auscultates bilateral fields AND epigastrium; confirms equal chest rise
    Critical4 pts
  • ETCO2 confirms tracheal placement
    Colorimetric (purple→yellow) or waveform ETCO2; does not accept placement without CO2 confirmation
    Critical4 pts
  • Tube secured; plan for definitive airway verbalized
    Secured at ~7–8 cm depth; monitors SpO2 recovery; states conversion to formal tracheostomy within 24–72h
    2 pts
  • Involves ENT/thoracic surgery for tracheostomy conversion
    Verbalizes surgical consult for definitive airway
    1 pt
Complication Probe Questions
QNo ETCO2 is detected after inserting the tube. SpO2 continues falling. What happened?
False passage / esophageal/paratracheal misplacement. Remove tube immediately. Re-identify CTM by direct finger palpation — landmark failure is the most common cause. Enlarge incision, confirm trachea by digital entry, reinsert under direct visualization. Return to BVM via oral airway if SpO2 allows reoxygenation.
QSignificant bleeding encountered at the incision. How do you manage this?
Airway takes priority over hemorrhage. Continue with cric. After tube secured, address bleeding with direct pressure, suture ligation, or packing. Major vessels at risk are the superior cricothyroid arteries (run across the upper third of CTM — reason to incise in the lower third). Involve ENT urgently if hemorrhage is severe.
QAre there absolute contraindications to cricothyrotomy?
No absolute contraindications in a true CICO scenario. Relative contraindications where alternate approaches are preferred first: age <8–10 (needle cric or tracheostomy preferred), suspected laryngeal fracture, known laryngotracheal pathology. Risk-benefit still favors cric if no other option exists.
QTwo failed CTM identification attempts in an obese patient. What is your next strategy?
Landmark failure approach: use bimanual "laryngeal handshake" — bilateral palpation from thyroid notch downward in midline. In extreme cases: ultrasound to identify CTM pre-incision if time allows, or aggressive midline incision with blunt dissection to find trachea. Do not repeat the same failed technique more than twice — change your strategy each attempt.
Facilitator Notes
Observations / Debrief Points
Procedure 03
Lumbar Puncture
Diagnostic CSF sampling with opening pressure. Focus on positioning, landmark identification, aseptic technique, and stylet replacement.
Pre-procedure screening: Resident must verbalize contraindication check — papilledema, focal deficits, coagulopathy (INR >1.5, plt <50k), anticoagulation, skin infection at site. CT head required if >60 y/o, immunocompromised, new seizure, or abnormal neuro exam.
Score
0/31
Performance
Equipment
LP tray (sterile drape, gauze)
Spinal needle 20–22g with stylet
Manometer with 3-way stopcock
Collection tubes ×4 (labeled 1–4)
Sterile gloves
Chlorhexidine prep
1% Lidocaine + 25g needle
Bandage/adhesive dressing
Positioning pillow/wedge
Assistant for patient hold
Technique — Scored Checklist
31 pts
  • Verbalizes contraindication screening
    Papilledema, focal deficits, coagulopathy, anticoagulation, skin infection; CT head obtained if indicated
    2 pts
  • Optimal patient positioning achieved
    Lateral decubitus: knees to chest, chin to chest, maximally flexed; OR seated leaning forward over pillow; spine parallel to bed edge; assistant holds position
    Critical4 pts
  • Correct interspace identified — L3-L4 or L4-L5
    Tuffier's line (iliac crest) = L4 vertebral body; targets L3-L4 or L4-L5; does NOT go above L2-L3 (spinal cord ends at L1-L2)
    Critical4 pts
  • Sterile technique maintained throughout
    Sterile gloves; chlorhexidine prep allowed to dry; sterile drape; field not contaminated
    Critical4 pts
  • Local anesthesia administered effectively
    25g needle; skin wheal; deeper infiltration to interspinous ligament; communicates with patient
    2 pts
  • Spinal needle inserted with stylet in place, bevel parallel to dural fibers
    Stylet in before insertion; bevel up in lateral decubitus (toward ceiling); toward patient's side if seated
    2 pts
  • Correct trajectory — slight cephalad angle toward umbilicus
    5–15° cephalad; midline; advances between spinous processes
    2 pts
  • Stylet removed intermittently to check for CSF
    Checks every 2–3 mm after initial resistance; does not advance blindly
    1 pt
  • CSF confirmed; opening pressure measured
    CSF flows freely; manometer attached; legs extended for accurate measurement; reads meniscus; documents OP (normal 8–20 cmH₂O)
    Critical4 pts
  • CSF collected in 4 sequentially labeled tubes (1–2 mL each)
    Tube 1 and 4: cell count (RBC clearing for traumatic tap vs SAH); tube 2: chemistry; tube 3: microbiology
    2 pts
  • Stylet replaced before needle removal
    Fully replaces stylet before withdrawing needle — reduces post-LP headache; commonly missed step
    Critical4 pts
  • Pressure applied; dressing placed; patient instructions given
    Gentle pressure at site; adhesive dressing; lie flat ×1h; return for positional headache
    2 pts
Complication Probe Questions
QCloudy yellow CSF, opening pressure 35 cmH₂O. What is happening and how urgent is this?
Bacterial meningitis until proven otherwise. Xanthochromia + elevated OP + cloudy CSF = septic meningitis with high ICP. Do not wait for culture results — antibiotics within 30–60 min of presentation. Send all 4 tubes and blood cultures; start empiric vancomycin + ceftriaxone ± ampicillin ± dexamethasone immediately.
QTubes 1 and 4 are bloody. Tube 4 has fewer RBCs than tube 1. What does this mean?
Traumatic tap — RBC count decreases from tube 1 to 4 as the needle stops traumatizing the vessel. In true SAH, blood is uniformly distributed with no clearing. If uncertainty: xanthochromia on spectrophotometry of tube 4 centrifuged at >12h from symptom onset is the gold standard.
QThree days after LP, patient has severe headache worse sitting up, resolves lying down. What is this and how do you treat it?
Post-dural puncture headache (PDPH) — CSF leak causes intracranial hypotension. Conservative: rest, hydration, caffeine 300 mg. Definitive: epidural blood patch 15–20 mL autologous blood — 70–98% success. Prevention: smaller gauge needle (22g), atraumatic pencil-point tip, replace stylet before removal.
QThree failed attempts with no CSF. What are your options?
Change patient position (seated vs. lateral). If still failing: fluoroscopy or ultrasound-guided LP via Radiology. In obese patients, ultrasound pre-procedurally marks midline and interspace. Never attempt more than 3–4 passes without reassessing strategy and involving an experienced operator.
Facilitator Notes
Observations / Debrief Points
Procedure 04
Pediatric Intubation
RSI and orotracheal intubation in a toddler (~12 kg, 18–24 months). Weight-based dosing, equipment sizing, sniffing position, multi-modal placement confirmation.
Reference: This scenario uses a 12 kg toddler. ETT: 4.0 uncuffed (have 3.5 and 4.5 available). Depth at lip: ~12 cm. Laryngoscope: Miller 1 blade.
Score
0/40
Performance
Equipment
Pediatric BVM + mask (size 2)
Laryngoscope: Miller 1 blade
ETT 4.0 uncuffed (+ 3.5 and 4.5)
Stylet (tip at Murphy's eye only)
Colorimetric ETCO2 detector
Yankauer + 8 Fr suction catheter
RSI drugs drawn up and labeled
SpO2, cardiac, BP monitors
Tape / ETT securing device
Shoulder roll (small folded towel)
RSI Drug Reference — 12 kg Toddler
DrugDose12 kg Amount
Atropine0.02 mg/kg0.24 mg IV
Min 0.1 mg · Give 2–3 min before induction
Ketamine1–2 mg/kg12–24 mg IV
Preferred — hemodynamic preservation
Propofol2–3 mg/kg24–36 mg IV
Alternative — caution hypotension
Succinylcholine2 mg/kg24 mg IV
⚠ Toddlers need 2 mg/kg (not 1.5); see contraindications
Rocuronium1.2 mg/kg14.4 mg IV
RSI dose; reverse with sugammadex 16 mg/kg
Sux contraindications: Suspected myopathy, hyperkalemia, crush injury >72h, denervation injury, MH susceptibility → use rocuronium.
RSI + Technique — Scored Checklist
40 pts
  • Equipment verified — SOAP-ME checklist
    Suction on; Oxygen flowing; Airway equipment (correct ETT, blade, BVM); Position ready; Medications drawn; Emergency backup present
    Critical4 pts
  • ETT size verbalized using correct formula
    Age/4 + 4 = 4.5 → rounds to 4.0 uncuffed for toddler; has 3.5 and 4.5 at bedside
    2 pts
  • Preoxygenation with 100% O₂ to SpO₂ ≥95%
    BVM with tight seal for ≥3 min; does not rush to intubate before adequate preoxygenation
    Critical4 pts
  • Sniffing position with shoulder roll
    Toddler's prominent occiput needs small shoulder roll (folded towel); ears to sternal notch alignment; head neutral/slight extension (not hyperextended)
    2 pts
  • Atropine given 2–3 min before induction
    0.02 mg/kg = 0.24 mg IV; prevents vagally-mediated bradycardia from laryngoscopy
    2 pts
  • RSI drugs in correct order with correct doses verbalized
    Induction THEN paralytic (within 30s): Ketamine 12–24 mg OR propofol 24–36 mg → Sux 24 mg or rocuronium 14.4 mg; doses stated aloud
    Critical4 pts
  • Waits for adequate paralysis before laryngoscopy
    Sux: 45–60s (fasciculations then flaccid); rocuronium: 60–75s; jaw relaxed before attempt
    2 pts
  • Laryngoscopy technique with Miller 1 blade
    Blade from right side of mouth; sweeps tongue left; Miller blade directly lifts epiglottis (different from Macintosh); steady upward traction — no levering
    3 pts
  • Vocal cords visualized before tube insertion
    Confirms both arytenoids and vocal cords; does not blindly advance; uses BURP or external laryngeal manipulation if view limited
    Critical4 pts
  • ETT passed through cords to correct depth
    Passes to vocal cord marking; removes laryngoscope; holds tube firmly against gum; depth = ETT size × 3 = ~12 cm at lip
    Critical4 pts
  • Multi-modal placement confirmation
    1) ETCO2 (purple→yellow); 2) Bilateral axillary breath sounds (not central — avoid false positive); 3) No gastric gurgling; 4) Equal chest rise; 5) SpO2 maintained
    Critical4 pts
  • ETT secured at correct depth with tape
    ~12 cm at lip; checked for right mainstem (unequal chest rise); secured with appropriate pediatric tape technique
    2 pts
  • Post-intubation management verbalized
    CXR for final tube position; sedation/analgesia ordered; ventilator settings; NG tube; reassess after any patient movement
    2 pts
Complication Probe Questions
QPost-intubation SpO₂ drops; breath sounds only on the right. What happened?
Right mainstem intubation. Pull tube back 1–2 cm while auscultating until left-sided sounds return. Toddler trachea is ~5 cm — small advancement causes right mainstem. Reconfirm depth at 12 cm; secure firmly.
QHeart rate drops to 50 bpm during laryngoscopy. Why and what do you do?
Vagal-mediated bradycardia from laryngoscopy — dominant cause of cardiovascular instability in pediatric intubation. Remove laryngoscope; provide 100% O₂ via BVM — HR usually recovers. If persistent: atropine 0.02 mg/kg IV. This is why atropine premedication is given routinely before RSI in toddlers.
QUnable to visualize cords after 30 sec; SpO₂ is 88% and dropping. What is your plan?
Failed intubation protocol: 1) Call for help. 2) Return to BVM — oxygenation is priority. 3) Reoxygenate to ≥95%. 4) Reassess: position, blade (try Mac or video laryngoscopy), BURP. 5) If reattempt fails: LMA as rescue airway. 6) Cannot ventilate/oxygenate → needle cric for toddler. Never >3 attempts without escalating.
QWhen is succinylcholine dangerous in a toddler and when do you use rocuronium instead?
Sux causes transient hyperkalemia (~0.5–1 mEq/L). Dangerous in: suspected myopathy, crush injury >72h, denervation injury, burns >48h, renal failure with hyperkalemia, MH susceptibility. Also caution in undiagnosed myopathy in children (Duchenne's). Use rocuronium 1.2 mg/kg as RSI-dose alternative; reverse with sugammadex 16 mg/kg if needed.
Facilitator Notes
Observations / Debrief Points
Procedure 05
ACLS Rhythm Management
Full ACLS spectrum. Residents interpret rhythms from the monitor and direct management. Score each encounter using the universal rubric below.
Universal Scoring Rubric — Per Rhythm Encounter
20 pts per encounter
  • Correct rhythm identification
    Names rhythm precisely and explains criteria used to identify it
    Critical4 pts
  • Correct initial priority action
    First intervention appropriate for rhythm (CPR for arrest, defib for VF/pVT, vagal for stable SVT, pacing for complete block); no harmful initial action
    Critical4 pts
  • Correct drug and dose verbalized
    Right drug; correct dose stated (e.g., "epinephrine 1 mg IV" not just "epi"); correct route; correct timing
    Critical4 pts
  • Correct device settings verbalized
    Energy selection, sync vs. async mode, pacing rate and mA; confirms mechanical capture by femoral pulse
    Critical4 pts
  • Reassessment after each intervention
    Checks pulse, rhythm, BP after every major intervention; adjusts plan based on response
    2 pts
  • Clear team communication and closed-loop
    Directs by name/role; verbalizes plan; closed-loop confirmations; minimizes CPR interruptions
    2 pts
Cardiac Arrest
Tachyarrhythmias
Bradyarrhythmias
Device Protocols
Ventricular FibrillationSHOCKABLE
Rate: Chaotic, no identifiable complexes
QRS: Absent — fibrillatory waves
Pulse: Absent
Pulseless VTSHOCKABLE
Rate: 150–300
QRS: Wide (>120ms), monomorphic, regular
Pulse: Absent
PEANON-SHOCKABLE
Rhythm: Organized electrical activity
QRS: Any — may look normal
Pulse: Absent — KEY finding
AsystoleNON-SHOCKABLE
Rhythm: Flat line (confirm ≥2 leads)
QRS: Absent
Pulse: Absent
VF / Pulseless VT Algorithm
1
Confirm no pulse → high-quality CPR (100–120/min, ≥2in, full recoil, minimize interruptions); IV/IO access
2
Charge defibrillator while CPR continues → clear → Shock: 200J biphasic (360J monophasic)
3
Immediately resume CPR ×2 min — no pulse check after first shock
4
Still shockable: Epinephrine 1 mg IV q3–5 min given during CPR cycles (not before shocks); give 1st dose during CPR after 2nd shock; shock again at 200J biphasic
5
After 3rd shock (still shockable): Amiodarone 300 mg IV push OR lidocaine 1–1.5 mg/kg; amiodarone 150 mg repeat ×1 if needed
6
Continue 2-min CPR cycles; treat reversible causes (H's & T's)
!
Do NOT pause CPR >10 sec for intubation; once intubated: continuous compressions + 1 breath/6 sec
PEA / Asystole Algorithm
1
Confirm no pulse (PEA may have normal-looking rhythm) → high-quality CPR immediately
2
Epinephrine 1 mg IV q3–5 min as soon as IV/IO access obtained
3
Identify and treat reversible causes (H's & T's) — this is the priority in PEA
4
Rhythm checks every 2 min; if VF/pVT appears → defibrillate; if ROSC → post-arrest care
!
Do NOT defibrillate PEA or asystole; confirm asystole in ≥2 leads
H's and T's — Reversible Causes of Arrest
H's
HypovolemiaFluid bolus; hemorrhage control
HypoxiaIntubate; 100% O₂; ventilate
Hydrogen ion (acidosis)Bicarbonate if severe; treat cause
Hypo/HyperkalemiaCalcium; insulin/glucose; bicarb
HypothermiaActive rewarming; don't declare death until warm
T's
Tension pneumothoraxNeedle decompression → chest tube
Tamponade (cardiac)Pericardiocentesis; FAST exam
ToxinsAntidote if available; Poison Control
Thrombosis (PE)Systemic thrombolytics; embolectomy
Thrombosis (coronary)STEMI → emergent PCI
Arrest Drug Reference
DrugIndicationDoseNotes
EpinephrineAll cardiac arrest1 mg IV/IO q3–5 minPush fast; flush 20 mL NS; elevate arm
AmiodaroneVF/pVT refractory to 2 shocks300 mg IV push → 150 mg ×1Dilute in D5W; hypotension with ROSC
LidocaineAlternate antiarrhythmic1–1.5 mg/kg IVMax 3 mg/kg cumulative
Sodium BicarbHyperkalemia, TCA OD, severe acidosis1 mEq/kg IVNOT routine — specific indications only
Calcium GluconateHyperkalemia, hypocalcemia1–2 g IV over 5–10 minDo not mix with bicarb
Arrest Complication Probe Questions
QROSC after 15 min CPR. BP 85/50, patient comatose. What are your immediate post-arrest priorities?
Post-ROSC care: 1) MAP ≥65 mmHg — fluids and norepinephrine; 2) Avoid hypoxia and hyperoxia — titrate O₂ to SpO₂ 94–98%; 3) Targeted Temperature Management 32–36°C ×24h for comatose survivors; 4) 12-lead ECG — emergent PCI if STEMI regardless of neuro status; 5) ABG, electrolytes, lactate; 6) Neurology consult.
QResident wants to shock what appears to be asystole. How do you respond?
Asystole is not shockable — there is no organized electrical activity to reset. However: confirm in ≥2 leads to rule out fine VF (which IS shockable and can mimic asystole). If any doubt about fine VF, one defibrillation attempt is reasonable. Continue CPR + epinephrine; treat reversible causes.
Facilitator Notes — Cardiac Arrest
Rhythm encounters scored / Debrief points
Stable Monomorphic VTWITH PULSE
Rate: 100–200 · QRS: Wide (>120ms), uniform
P waves: AV dissociation (P unrelated to QRS)
Pulse: Present, BP maintained
Unstable VTCARDIOVERT
Signs: Hypotension, AMS, ischemic chest pain, pulmonary edema
Pulse: Present but hemodynamically compromised
SVT — Narrow ComplexWITH PULSE
Rate: 150–220+ · QRS: Narrow (<120ms), regular
P waves: Hidden in T waves or retrograde
Note: Rate 150 → always rule out flutter
AFib with RVRWITH PULSE
Rate: >100 ventricular
Rhythm: Irregularly irregular — KEY feature
P waves: Absent; fibrillatory baseline
Atrial FlutterWITH PULSE
Rate: Atrial 300, ventricular 150 (2:1 block typical)
Rhythm: Regular · P waves: Sawtooth flutter waves — best seen in II, III, aVF
Key: Rate exactly 150 → always consider flutter before SVT
Torsades de PointesSPECIAL
Rate: 200–300
QRS: Polymorphic — twisting axis around baseline
Preceding QTc: Prolonged (>500ms)
VT with Pulse Management
First: Stable or unstable? Unstable (AMS, hypotension, ischemic CP, pulm edema) → synchronized cardioversion immediately.
1
Stable VT: IV access; 12-lead ECG; O₂; monitoring
2
Amiodarone 150 mg IV over 10 min; then 1 mg/min ×6h → 0.5 mg/min ×18h
3
Alt: Lidocaine 1–1.5 mg/kg IV (max 3 mg/kg)
4
Unstable VT: Sedate if possible → Sync cardioversion 100J biphasic
Cardioversion — Unstable VT
Mode
SYNC
Energy
100J biphasic
Escalation
150J → 200J
Confirm before shock
Sync markers on R waves
SVT Management
1
Vagal maneuvers first — modified Valsalva (supine, legs elevated), carotid sinus massage, cold water to face
2
Adenosine 6 mg rapid IV push + immediate 20 mL NS flush; antecubital preferred
3
No conversion: Adenosine 12 mg rapid push; may repeat 12 mg once (max 30 mg total)
4
Refractory: Diltiazem 0.25 mg/kg IV over 2 min OR metoprolol 5 mg IV
5
Unstable SVT: Sedation → Sync cardioversion 50–100J biphasic
WPW: Never give adenosine, β-blockers, or CCBs if WPW suspected (delta waves, short PR) — accelerates accessory pathway → VF. Use amiodarone or cardioversion.
AFib with RVR
1
Stable (rate control): Diltiazem 0.25 mg/kg IV over 2 min; repeat 0.35 mg/kg; then infusion 5–15 mg/h. Or metoprolol 2.5–5 mg IV ×3
2
Onset ≥48h: anticoagulate before cardioversion (or TEE to rule out LAA thrombus) unless unstable
3
HFrEF or instability: Amiodarone 150 mg IV over 10 min
4
Unstable: Sync cardioversion 120–200J biphasic
Cardioversion — AFib
Mode
SYNC
AFib energy
120–200J biphasic
AFl energy
50–100J biphasic
Torsades de Pointes
1
Pulseless: Unsynchronized defibrillation 200J — SYNC mode fails on irregular rhythm
2
Pulse present: Magnesium sulfate 1–2 g IV over 5–20 min; may repeat; then infusion
3
Remove QT-prolonging agents; correct K⁺ >4 mEq/L and Mg²⁺ >2 mg/dL
4
Recurrent TdP: overdrive pacing at 90–100 bpm shortens QT; isoproterenol if pacing unavailable
Do NOT use amiodarone in TdP — prolongs QT and worsens the arrhythmia.
Tachyarrhythmia Probe Questions
QAdenosine converts SVT briefly to sinus, then immediately returns to SVT. What does this tell you?
Diagnostic — confirms AV nodal re-entrant tachycardia (AVNRT) or AVRT; rules out VT (which would not convert). Next: repeat 12 mg adenosine or use diltiazem/metoprolol. Consider EP referral for ablation. Always have atropine and crash cart ready when giving adenosine — brief asystole is expected and normal.
QAFib with RVR, wide QRS complexes, and delta waves visible on a prior ECG. How does this change management?
WPW with AFib — life-threatening. Accessory pathway bypasses AV node and can conduct at very high rates, precipitating VF. Avoid ALL AV nodal blockers (adenosine, digoxin, diltiazem, beta-blockers). Use Procainamide 20–50 mg/min IV (slows accessory pathway) or emergent synchronized cardioversion if unstable.
QSYNC mode selected but device is not firing. What is happening and what do you do?
Device cannot find a clear R wave to synchronize with (small amplitude QRS, noise, lead artifact, T wave sensing). Solutions: reposition leads/pads, change lead, increase gain. Never switch to ASYNC for a patient with a pulse — risk of R-on-T → VF. If SYNC repeatedly fails in an unstable patient: the risk of collapse outweighs R-on-T risk → switch to ASYNC.
Facilitator Notes — Tachyarrhythmias
Notes
Symptomatic Sinus BradycardiaBRADY
Rate: <60 · P waves: Normal, before each QRS
PR: Normal · Symptoms: hypotension, syncope, AMS
1st Degree AV BlockMONITOR
PR interval: >200ms (prolonged but constant)
P waves: Every P followed by QRS
Usually asymptomatic — monitor only
2nd Degree — Mobitz I (Wenckebach)USUALLY BENIGN
PR: Progressive prolongation → dropped QRS
QRS: Usually narrow · "Grouped beating"
Nodal — rarely requires pacing
2nd Degree — Mobitz IIDANGEROUS
PR: Constant → sudden non-conducted P wave
QRS: Usually wide (infranodal)
High risk of progression to complete block
3rd Degree — Complete AV BlockPACE URGENTLY
P waves: Completely dissociated from QRS
Escape rate: 20–40 bpm (ventricular or junctional)
Transcutaneous pacing immediately
Junctional EscapeBRADY
Rate: 40–60 bpm · QRS: Narrow
P waves: Absent, inverted, or retrograde
Occurs when SA node fails
Symptomatic Bradycardia Algorithm
Symptomatic = hypotension, AMS, ischemic CP, or pulm edema caused by the bradycardia. Asymptomatic bradycardia requires no treatment regardless of rate.
1
Identify reversible causes: β-blocker/CCB toxicity, inferior STEMI, hyperkalemia, hypothyroidism, increased ICP
2
Atropine 1 mg IV; repeat q3–5 min; max 3 mg total. Effective for sinus brady and Wenckebach; may NOT work for infranodal blocks
3
Atropine fails: Transcutaneous pacing immediately; OR dopamine 2–10 mcg/kg/min; OR epinephrine 2–10 mcg/min
4
Prepare for transvenous pacing if Mobitz II or complete heart block confirmed
Brady Drug Reference
DrugDose
Atropine1 mg IV q3–5 min
Max 3 mg · 1st line
Dopamine2–20 mcg/kg/min infusion
Titrate to effect
Epinephrine2–10 mcg/min infusion
0.1–0.5 mcg/kg/min
Glucagon3–10 mg IV bolus
β-blocker/CCB OD only
Brady Complication Probe Questions
QAtropine 3 mg given for complete heart block (rate 30, BP 70/40) with no improvement. What is next?
Transcutaneous pacing (TCP) immediately. Atropine has no effect on infranodal blocks — it acts on the SA/AV node via vagal tone. Complete block with wide QRS escape is almost always infranodal. Start pads, rate 60–80, begin at 50 mA and increase until electrical capture. Verify mechanical capture by femoral pulse — radial pulse reflects pacer artifact, not actual CO. Provide sedation/analgesia.
QYou see pacer spikes and wide QRS complexes on the monitor but patient remains hypotensive with no femoral pulse. What is this?
Electrical capture without mechanical capture — paced QRS is present but myocardium isn't contracting effectively (severe ischemia, metabolic derangement, massive PE). Never rely on ECG alone. Always palpate femoral or use Doppler. Optimize underlying physiology; increase output; consider underlying cause. This is why confirming mechanical capture is a critical scoring item.
QHow do you differentiate Mobitz I (Wenckebach) from Mobitz II and why does it matter?
Wenckebach: Progressive PR prolongation before each dropped QRS → PR resets. Narrow QRS. Nodal block. Generally benign. Mobitz II: Constant PR → sudden non-conducted P wave without warning. Wide QRS. Infranodal. Clinical importance: Mobitz II carries high risk of progression to complete block, especially in anterior STEMI (bilateral bundle branch disease). Requires immediate transvenous pacing preparation even if currently asymptomatic.
Facilitator Notes — Bradyarrhythmias
Notes
Defibrillation
Settings
Mode
ASYNC
Biphasic energy
200J
Monophasic energy
360J
1
Confirm no pulse; CPR ongoing while charging
2
Pads: right infraclavicular + left lateral 5th ICS
3
ASYNC mode — never SYNC for pulseless
4
Clear: visual sweep → shock
5
Immediately resume CPR — no pulse check
Sync Cardioversion
Energy by Rhythm
Unstable VT
100J
SVT
50–100J
Atrial flutter
50–100J
Atrial fibrillation
120–200J
1
Confirm patient has a pulse
2
Press SYNC — confirm markers on R waves
3
Sedate if possible (midazolam ± fentanyl)
4
Hold button until device fires (sync delay expected); re-SYNC before each additional shock
!
R-on-T → VF if delivered during T wave. SYNC mode is critical for patients with a pulse.
Transcutaneous Pacing
Settings
Mode
DEMAND
Rate
60–80 bpm
Starting mA
50–70 mA
Final setting
10% above threshold
1
Pads: anterior-posterior preferred (left parasternal + left infrascapular)
2
DEMAND mode; rate 60–80; start 50–70 mA
3
Increase mA by 5–10 until electrical capture (wide QRS after spike)
4
Confirm mechanical capture — palpate femoral artery (radial reflects artifact)
5
Sedate: midazolam + fentanyl — TCP is painful in conscious patients
6
Arrange transvenous pacing — TCP is a bridge only
Device Probe Questions
QSYNC mode selected but the device won't fire after several seconds. Patient is worsening. What do you do?
Device cannot find a clear R wave. Causes: poor ECG quality, motion artifact, small QRS amplitude, T waves sensed instead of R waves. Solutions: reposition/replace electrodes, change lead, ensure monitoring leads (not just pads) are connected. If SYNC mode repeatedly fails and patient is deteriorating → switch to ASYNC mode and defibrillate. Risk of cardiovascular collapse outweighs R-on-T risk.
QPost-cardioversion of AFib, patient develops ST elevations and chest pain within minutes. What happened?
Post-cardioversion coronary embolism — LAA thrombus dislodged during cardioversion. This is why anticoagulation ≥3 weeks before elective cardioversion (or TEE to rule out LAA thrombus) is standard for AFib ≥48h. Management: 12-lead ECG, STEMI activation, emergent PCI.
QUnstable patient in VT with a very faint carotid pulse. SYNC or ASYNC?
If pulse confirmed → SYNC cardioversion 100J. If cannot confirm pulse within 10 seconds, or rhythm is polymorphic VT → ASYNC defibrillate. General rule: when in doubt on a crashing patient, treat as pulseless. Hesitation should never delay the shock.
Facilitator Notes — Devices
Notes
Procedure 06
Paracentesis
Diagnostic and large-volume therapeutic paracentesis using ultrasound guidance. Z-track technique, safe site selection, and albumin replacement are the three pillars of safe practice.
Pre-procedure screening: Resident must verbalize — coagulopathy check (INR, platelets), active skin infection at site, known bowel obstruction/ileus, pregnancy, prior abdominal surgeries (adhesions, bowel adherence to abdominal wall). Confirm diagnostic vs. therapeutic intent before proceeding.
Score
0/35
Performance
Equipment
Sterile gloves, mask, drape
Chlorhexidine prep sticks
1% Lidocaine + 25g/22g needles
10 mL + 60 mL syringes
Paracentesis kit (catheter-over-needle 14–16g) or 18g angiocath
3-way stopcock + IV tubing
Large drainage bags (for LVP)
Sample tubes: EDTA, SST, culture bottles
Blood culture bottles (inoculate at bedside)
Ultrasound + linear or curvilinear probe
Albumin 25% (for LVP — calculate before starting)
Bandage/occlusive dressing
Diagnostic Lab Panel
TestTube / ContainerPurpose
Cell count + diffEDTA (purple top)PMN ≥250 = SBP; RBC >50k = hemorrhagic
Total protein + LDHSST (gold/red top)Exudate vs transudate (rarely needed in ascites)
Albumin (fluid)SSTCalculate SAAG = serum albumin − fluid albumin
GlucoseSSTLow in SBP, TB, malignancy
Gram stain + cultureBlood culture bottlesInoculate at bedside — dramatically increases SBP yield vs lab
CytologyLarge SST or heparinIf malignancy suspected; send ≥60 mL
AmylaseSSTIf pancreatic ascites suspected
Serum albumin (paired)Blood drawRequired to calculate SAAG; draw same day
SAAG interpretation: ≥1.1 g/dL = portal hypertension (cirrhosis, CHF, Budd-Chiari) · <1.1 g/dL = non-portal (TB peritonitis, malignancy, pancreatitis, nephrotic)
Albumin Replacement Reference (LVP)
When: Replace albumin for any tap >5 L. Prevents post-paracentesis circulatory dysfunction (PPCD) — vasodilation, AKI, encephalopathy, increased mortality.
Volume RemovedAlbumin Dose
<5 L (diagnostic)No replacement required
5–10 L6–8 g per liter removed
e.g., 6L removed → 36–48 g albumin IV
>10 L8 g per liter removed
Give after procedure completion; use 25% albumin
Alternative: Dextran-70 or other volume expanders are less effective than albumin for PPCD prevention per current evidence.
Technique — Scored Checklist
35 pts
  • Pre-procedure screening verbalized
    Confirms coagulopathy, skin infection, bowel obstruction, prior surgeries; verbalizes diagnostic vs. therapeutic intent; obtains verbal consent
    2 pts
  • Patient positioning — supine with slight left lateral tilt (or lateral decubitus)
    Supine preferred; left lateral decubitus shifts bowel away from LLQ; allows fluid to pool dependently; bed flat
    2 pts
  • Ultrasound identifies adequate fluid pocket and safe window
    Confirms free-flowing (anechoic) fluid pocket; depth ≥3 cm; identifies bowel loops, bladder, and vessels in planned path; marks site with skin indentation or pen; NOT a blind procedure
    Critical4 pts
  • Site selection lateral to rectus abdominis — avoids inferior epigastric arteries
    LLQ (preferred — less bowel, avoids enlarged liver/spleen) or RLQ; inserts lateral to the lateral edge of rectus sheath; midline acceptable only 2 cm below umbilicus if LLQ/RLQ inaccessible; avoids surgical scars (adhesion risk)
    Critical4 pts
  • Chlorhexidine skin prep — allow to dry; sterile drape placed
    Wide prep area; ≥30 sec scrub; sterile field established before gloving
    2 pts
  • Local anesthesia to peritoneal wall — not just skin
    25g skin wheal → 22g deep infiltration tracking down to peritoneum; aspirates as advancing; "pop" sensation indicates peritoneal entry with lidocaine needle; this confirms depth and is a pre-probe before paracentesis needle
    2 pts
  • Z-track technique performed correctly
    Before inserting paracentesis needle: pulls skin 1–2 cm caudally (or laterally) while inserting needle perpendicular; releases skin after needle in peritoneum — creates angled tract that seals on withdrawal and prevents persistent ascitic leak
    Critical4 pts
  • Needle/catheter advanced with continuous aspiration until fluid returns
    Slow controlled advancement; aspiration confirms peritoneal entry (straw-colored/yellow fluid); stops advancing once fluid returns; threads catheter off needle and removes needle (kit-based technique); connects to 60 mL syringe or drainage tubing
    3 pts
  • Diagnostic vs. therapeutic volume decision verbalized
    Diagnostic: 30–60 mL minimum for full lab panel; Therapeutic/LVP: drain until dry or goal volume met; states rationale for choice
    2 pts
  • Labs sent correctly — blood culture bottles inoculated at bedside
    Cell count/diff (EDTA); albumin + total protein + glucose + LDH (SST); culture bottles inoculated at bedside with 10 mL each (not sent to lab in syringe); cytology if malignancy suspected; serum albumin ordered same day for SAAG
    Critical4 pts
  • Albumin replacement ordered for large-volume paracentesis (>5 L)
    States dose: 6–8 g per liter removed; uses 25% albumin IV; understands prevention of post-paracentesis circulatory dysfunction (PPCD); ordered to infuse after procedure completion
    Critical4 pts
  • Catheter removed; pressure applied; dressing placed; site inspected
    Removes catheter; applies pressure; occlusive dressing; inspects for persistent leak (ask patient to Valsalva); documents output volume
    2 pts
Complication Probe Questions
QAscitic fluid aspirated is bloody (red-tinged). How do you differentiate traumatic tap from hemorrhagic ascites?
Traumatic tap: Blood often clears as fluid continues to drain; fluid may streak rather than be uniformly bloody; RBC count typically <10,000/mm³. Hemorrhagic ascites: uniformly bloody throughout; common in hepatocellular carcinoma, trauma, TB, or ruptured tumor. Key action: send fluid for RBC count and hematocrit. If hematocrit of fluid >50% of peripheral blood hematocrit → hemoperitoneum, not traumatic tap → urgent surgical or IR consult. Stop the tap; apply pressure; assess hemodynamics.
QFour days after LVP (8 liters removed), the patient returns with AKI, worsening encephalopathy, and sodium of 126. No albumin was given. What is this and what could have prevented it?
Post-paracentesis circulatory dysfunction (PPCD). Large-volume paracentesis triggers massive splanchnic vasodilation via the renin-angiotensin system — effective circulating volume falls, activating vasoconstrictive and sodium-retaining responses → AKI, worsening ascites recurrence, hyponatremia, encephalopathy, and increased mortality. Prevention: albumin 6–8 g per liter removed IV after the procedure. This is standard of care for any tap >5L and is a critical item in this checklist.
QAscitic fluid cell count returns: WBC 800/mm³ with 85% PMNs. What is your diagnosis and immediate management?
Spontaneous bacterial peritonitis (SBP) — PMN count ≥250 cells/mm³ is diagnostic, even before culture results. Do not wait for culture. Immediate management: IV cefotaxime 2g q8h (or ceftriaxone 1g q24h) is first-line empiric therapy; albumin 1.5 g/kg IV at diagnosis + 1 g/kg on day 3 reduces renal failure and mortality. SBP prophylaxis after the episode: norfloxacin or trimethoprim-sulfamethoxazole. Note: culture is positive in only ~40% of SBP cases — a negative culture does NOT rule out SBP if PMN ≥250.
QPost-procedure, the patient has persistent clear fluid leaking from the puncture site through the dressing. What happened and how do you manage it?
Ascitic leak — occurs when the Z-track technique was not used or was inadequate, leaving a direct channel from peritoneum to skin. Management: place a purse-string suture at the puncture site (0-prolene or 2-0 nylon); apply an ostomy bag to collect and measure output if suture fails; consider tight pressure dressing + positioning to decompress peritoneum. For recurrent or severe leaks: loop diuresis (furosemide + spironolactone) to reduce intraperitoneal pressure while awaiting TIPS or repeat tap.
QWhat is the threshold INR or platelet count at which you would defer paracentesis?
There is no validated INR or platelet cutoff for paracentesis. Unlike thoracentesis or LP, the current evidence does not support routine FFP or platelet transfusion before paracentesis in cirrhotic patients, even with severe coagulopathy (INR >2.5, platelets <50k). Large observational studies show complication rates are not significantly elevated in cirrhosis regardless of INR. The procedure should be deferred if there is clinically evident DIC, active fibrinolysis, or skin infection at the site. Prophylactic transfusion wastes blood products and carries transfusion risks without benefit.
Facilitator Notes
Observations / Debrief Points
Procedure 07
Thoracentesis
Diagnostic and therapeutic pleural fluid removal. Ultrasound guidance is mandatory. The three most critical technical errors are: entering below the rib, exceeding safe drainage volume, and failing to order Light's criteria labs.
Pre-procedure screening: Resident must verbalize — coagulopathy check, anticoagulation status, skin infection at site, bilateral effusions (do NOT tap both sides same day — risk of bilateral re-expansion edema), mechanical ventilation (higher pneumothorax risk — relative contraindication), contralateral lung disease. Confirm diagnostic vs. therapeutic intent.
Score
0/36
Performance
Equipment
Sterile gloves, gown, mask, drape
Chlorhexidine prep sticks
1% Lidocaine + 25g + 22g needles
Thoracentesis kit (catheter-over-needle 14–16g)
60 mL syringe
3-way stopcock + IV tubing
Collection container (1–1.5L max)
Sample tubes: EDTA, SST, heparinized (ABG syringe for pH)
Blood culture bottles (if infection suspected)
Ultrasound + linear or curvilinear probe
Occlusive (Tegaderm) dressing
SpO2 monitor
Pleural Fluid Lab Panel + Light's Criteria
TestContainerPurpose
Cell count + diffEDTA (purple)Lymphocyte-predominant → TB, malignancy; PMN-predominant → parapneumonic, empyema
Total proteinSST (gold)Light's criterion #1: fluid protein / serum protein >0.5 = exudate
LDHSSTLight's #2: fluid LDH / serum LDH >0.6 = exudate; Light's #3: fluid LDH >2/3 ULN = exudate
GlucoseSSTLow (<60 mg/dL) = empyema, rheumatoid, malignancy, TB
pHABG syringe (heparin)<7.2 = complicated parapneumonic/empyema → needs chest tube; transport on ice to ABG machine
Gram stain + cultureCulture bottlesInoculate aerobic + anaerobic bottles at bedside
CytologyHeparinized (large volume)Malignant effusion; send ≥60 mL for best sensitivity
Serum protein + LDHBlood draw (paired)Required for Light's criteria; drawn same day
Light's criteria — exudate if ANY ONE: (1) Pleural protein / serum protein >0.5 · (2) Pleural LDH / serum LDH >0.6 · (3) Pleural LDH >2/3 upper limit of normal serum LDH. Sensitivity 98%, specificity 83%. If borderline: add serum-pleural albumin gradient (exudate if <1.2 g/dL) — corrects for diuretic effect on transudates.
Technique — Scored Checklist
36 pts
  • Pre-procedure screening verbalized
    Coagulopathy, anticoagulation, skin infection, mechanical ventilation status, bilateral effusions (don't tap both sides same day); diagnostic vs. therapeutic decision stated; SpO2 baseline documented
    2 pts
  • Patient in correct position — seated upright, leaning forward over table
    Patient seated on edge of bed, arms resting forward on bedside table or pillow; this position: lowers diaphragm, widens rib spaces, and causes fluid to pool dependently; if unable to sit → lateral decubitus with affected side DOWN; never supine for standard thoracentesis
    Critical4 pts
  • Ultrasound identifies effusion, size, loculation; marks safe site
    Confirms free-flowing hypoechoic fluid (loculations = complex effusion — may need guided needle in real time); measures fluid depth; identifies diaphragm, lung, and fluid level; marks site with skin indentation or pen; confirms fluid level at end-expiration; notes relation to spleen (left) and liver (right)
    Critical4 pts
  • Site: 1–2 interspaces BELOW fluid level on ultrasound; no lower than 9th ICS
    Entry point: 1–2 ribs below the upper fluid level found on US; posterior approach (posterior axillary line) preferred for maximum fluid pooling; never below the 9th intercostal space (diaphragm injury risk)
    2 pts
  • Chlorhexidine prep — allow to dry; sterile drape applied
    Wide prep area over posterior thorax; ≥30 sec scrub; sterile field established
    2 pts
  • Needle inserted just ABOVE the superior rib margin — not below the rib
    Neurovascular bundle (intercostal nerve, artery, vein) runs in the costal groove along the INFERIOR margin of each rib → inserting below the rib causes hemorrhage or neuralgia. The needle "walks" up over the top of the lower rib and enters the pleural space just above it. This is the single most important technical element of thoracentesis.
    Critical4 pts
  • Local anesthesia administered using "walking" technique
    25g skin wheal → 22g needle walks over superior rib margin with constant aspiration while injecting lidocaine; anesthetizes skin, subcutaneous tissue, intercostal muscle, and parietal pleura; confirms pleural space entry when fluid returns during anesthesia (depth marker)
    3 pts
  • Thoracentesis needle/catheter advanced with continuous aspiration; pleural fluid confirmed
    Advanced using same angle as anesthesia needle; stops advancing once fluid returns freely; advances catheter off needle (kit) or holds needle position; connects to 60 mL syringe via 3-way stopcock or to drainage tubing for therapeutic tap
    2 pts
  • Labs drawn first (diagnostic aliquot) before full therapeutic drainage
    Even for therapeutic tap: draws initial 30–60 mL diagnostic sample into labeled tubes before opening to drainage bag; inoculates culture bottles at bedside; sends paired serum labs (protein, LDH, albumin) same day
    2 pts
  • Volume limited to ≤1,000–1,500 mL per session
    Verbalizes volume limit; stops at 1,000–1,500 mL even if more fluid remains; exceeding this risks re-expansion pulmonary edema (RPE); also stops if patient develops chest tightness, cough, or hypoxia; if patient had trapped lung on CXR pre-procedure the limit may be lower (monitor pleural pressure if manometer available)
    Critical4 pts
  • Needle/catheter removed during exhalation or Valsalva; occlusive dressing applied
    Instructs patient to exhale fully or perform Valsalva (increases intrathoracic pressure → prevents air entry); removes quickly and applies occlusive Tegaderm immediately; avoids accidental pneumothorax at removal
    2 pts
  • Post-procedure CXR ordered; patient monitored for ≥30–60 min
    CXR confirms pneumothorax, residual effusion, and lung re-expansion; SpO2 monitored continuously for ≥30 min; if pneumothorax on CXR: small/asymptomatic may observe, expanding or symptomatic → chest tube; if patient develops severe dyspnea or re-expansion edema → O₂, possibly intubation
    Critical4 pts
  • Light's criteria labs ordered and results interpreted correctly
    Verbalized or ordered: pleural AND serum protein + LDH drawn same day; correctly applies Light's criteria (any 1 of 3 met = exudate); if borderline: mentions serum-pleural albumin gradient correction for diuretic effect
    3 pts
Complication Probe Questions
QPost-procedure CXR shows a new 15% pneumothorax on the ipsilateral side. Patient's SpO2 is 96% on room air and she feels well. How do you manage this?
Small asymptomatic pneumothorax after thoracentesis — does not require immediate chest tube. Management: 100% O₂ by NRB to accelerate nitrogen absorption (1 cm pneumothorax resolves ~1–1.5% per day on room air vs much faster on 100% O₂); repeat CXR in 4–6 hours; admit for monitoring if the patient requires it clinically. Chest tube is indicated for: pneumothorax >20–25%, symptomatic, expanding on repeat CXR, or tension physiology. Prevention: always have the patient exhale/Valsalva during needle removal; use ultrasound guidance.
QYou've drained 1,100 mL and the patient develops severe cough and progressive hypoxia. The CXR shows a new ipsilateral infiltrate. What happened?
Re-expansion pulmonary edema (RPE) — occurs when chronically collapsed lung rapidly re-expands. The previously atelectatic lung has increased vascular permeability; rapid pressure equalization causes fluid shifts into the parenchyma. Incidence increases significantly with large volumes and long-standing effusions. Management: stop drainage immediately, supplemental oxygen, upright positioning; severe cases may require CPAP or mechanical ventilation. Prevention: limit drainage to 1,000–1,500 mL per session; monitor pleural pressure with a manometer if available (stop at <−20 cmH₂O).
QLight's criteria are met (exudate). WBC is 12,000/mm³ with 95% PMNs and pH is 7.10. What does this mean and what is the management?
Complicated parapneumonic effusion / empyema. pH <7.2 in the setting of a PMN-predominant exudate with clinical infection indicates that the effusion will NOT resolve with antibiotics alone. Chest tube drainage is required — or image-guided drain if loculated. Empiric antibiotics covering gram-positives, gram-negatives, and anaerobes (piperacillin-tazobactam or cefepime + metronidazole). If loculated: consider tPA + DNase instillation via chest tube. Thoracic surgery consult for decortication if fibropurulent/organizing stage.
QThe pleural fluid meets Light's exudate criteria for protein but the clinical picture suggests the patient has CHF. What concept explains this and how do you refine the diagnosis?
Light's criteria overcall exudate in diuretic-treated transudates. Diuretics concentrate pleural fluid protein and LDH relative to serum, causing falsely elevated ratios. The correction: use the serum-pleural albumin gradient — if >1.2 g/dL, the effusion is a transudate despite meeting Light's exudate criteria. Also check serum BNP (elevated CHF), serum-to-pleural protein gradient >3.1 g/dL = transudate. Clinical context (bilateral effusions, peripheral edema, elevated BNP, cardiomegaly) supports the CHF diagnosis; repeat thoracentesis after diuresis would show classic transudate values.
QThe patient had a thoracentesis 10 minutes ago and now suddenly develops hypotension, SpO2 of 80%, and absent breath sounds on the CONTRALATERAL side. What happened?
Tension pneumothorax — air entered during the procedure, and with positive pressure ventilation or respiratory effort, a tension physiology developed. Note the contralateral absent breath sounds — the mediastinum has shifted away from the affected side. This is a clinical emergency: do not wait for CXR. Immediate needle decompression: 14g angiocath at 2nd ICS midclavicular line ipsilateral to the procedure site; rush to large-bore chest tube immediately after. Prevention: always remove the needle/catheter while patient exhales and cover site instantly with occlusive dressing.
Facilitator Notes
Observations / Debrief Points